Photo de Mohammad-Ali Jenabian

Mohammad-Ali Jenabian

Département des sciences biologiques

Poste : Professeur

Courriel :

Téléphone : (514) 987-3000 poste 6794

Local : SB-3385

Domaines d'expertise

  • Virologie
  • Immunologie
  • VIH/SIDA et Santé
  • Inflammation
  • Immunoregulation


  • Français
  • Anglais
  • Persan
  • Général
  • Enseignement et supervision
  • Publications
  • Communications
  • Réalisations
  • Distinctions
  • Services à la collectivité

Cheminement académique

2011-2014: Chercheur Postdoctoral, Immunologie Clinique, Institut de recherche du Centre universitaire de santé McGill, Université McGill, Montréal, Québec, Canada.

2009-2011: Chercheur Postdoctoral, Immunologie Fondamentale, Institut Mondor de Recherche Biomédicale (INSERM U955), Université Paris-Est Créteil (Paris XII), Paris, France.

2009: Docteur ès Sciences (Ph.D.), Virologie, Centre de Recherche Biomédicale des Cordeliers (INSERM U743) et Hôpital Européen Georges-Pompidou, Université Pierre et Marie Curie (Paris VI), Paris, France.

2003: Docteur en Médicine Vétérinaire (D.V.M.), Faculté de Médicine Vétérinaire, Université de Karaj, Karaj, Iran.

Liens d’intérêt

Unités de recherche

  • Centre de recherches biomédicales (BIOMED)

Projets de recherche en cours

  • Aucune donnée disponible pour cette section.

Partenaires (organismes, entreprises)

  • Réseau Sida et Maladies Infectieuses, Le Fonds de recherche du Québec - Santé (FRQ-S)
  • Réseau de Thérapie Cellulaire et Tissulaire, (ThéCell), Le Fonds de recherche du Québec - Santé (FRQ-S)
  • Réseau Canadien pour les essais VIH des IRSC (CTN)
  • Consortium canadien de recherche sur la guérison du VIH (CanCURE)
  • Regroupement stratégique FRQ-NT, centre de recherche en infectiologie porcine et avicole (CRIPA)

Prix et distinctions


Iannello, A., Samarani, S., Allam, O., et al. (2017). A potentially protective role of IL-18 Binding Protein in HIV-infected Long-Term Non-Progressors. Cytokine, 90, 96–99.

Allam, O., Samarani, S., Jenabian, M.-A., et al. (2017). Differential synthesis and release of IL-18 and IL-18 Binding Protein from human platelets and their implications for HIV infection. Cytokine, 90, 144–154.

Mossoro-Kpinde, C.D., Mboumba Bouassa, R.-S., Jenabian, M.-A., et al. (2016). Analytical Performances of Human Immunodeficiency Virus Type 1 RNA-Based Amplix® Real-Time PCR Platform for HIV-1 RNA Quantification. AIDS Research and Treatment, 2016, Article ID 7954810.

Huang, Y., Hoque, M.T., Jenabian, M.-A., et al. (2016). Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site. Journal of Antimicrobial Chemotherapy, 71(7), 1954–1965.

Ahmad, A., Mehraj, V., Jenabian, M.-A., Samarani, S., Tremblay, C. et Routy, J.-P. (2016). Combination antiretroviral therapy and indoleamine 2,3-dioxygenase in HIV infections: challenges and new opportunities. AIDS, 30(11), 1839–1841.

Aounallah, M., Dagenais-Lussier, X., El-Far, M., et al. (2016). Current topics in HIV pathogenesis, part 2: Inflammation drives a Warburg-like effect on the metabolism of HIV-infected subjects. Cytokine & Growth Factor Reviews, 28, 1–10.

Mossoro-Kpinde, C.D., Jenabian, M.-A., Gody, J.C., et al. (2016). Evaluation of the Upgraded Version 2.0 of the Roche COBAS® AmpliPrep/COBAS® TaqMan HIV-1 Qualitative Assay in Central African Children. Open AIDS Journal, 10, 158–163.

Samarani, S., Allam, O., Sagala, P., et al. (2016). Imbalanced production of IL-18 and its antagonist in human diseases, and its implications for HIV-1 infection. Cytokine, 82, 38–51.

Jenabian, M.-A., Costiniuk, C.T., Mehraj, V., et al. (2016). Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults. AIDS, 30(18), 2777–2786.

Jenabian, M.-A., Mehraj, V., Costiniuk, C.T., et al. (2016). Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients. Journal of Acquired Immune Deficiency Syndromes, 71(3), 254–262.

Wacleche, V.S., Goulet, J.-P., Gosselin, A., et al. (2016). New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy. Retrovirology, 13(59).

Mehraj, V., Jenabian, M.-A., Ponte, R., et al. (2016). The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection. AIDS, 30(10), 1617–1627.

Routy, J.-P., Angel, J., Patel, M., et al. (2015). Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy. HIV Medicine, 16(1), 48–56.

Routy, J.-P., Mehraj, V., Vyboh, K., Cao, W., Kema, I. et Jenabian, M.-A. (2015). Clinical Relevance of Kynurenine Pathway in HIV/AIDS: An Immune Checkpoint at the Crossroads of Metabolism and Inflammation. AIDS Reviews, 17(2), 96–106. Récupéré de

Hubert, A., Subra, C., Jenabian, M.-A., et al. (2015). Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression. Journal of Acquired Immune Deficiency Syndromes, 70(3), 219–227.

Vyboh, K., Jenabian, M.-A., Mehraj, V. et Routy, J.-P. (2015). HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets. Journal of Immunology Research, 2015, Article ID 614127.

Costiniuk, C.T. et Jenabian, M.-A. (2015). HIV reservoir dynamics in the face of highly active antiretroviral therapy. AIDS Patient Care and STDs, 29(2), 55–68.

Cleret-Buhot, A., Zhang, Y., Planas, D., et al. (2015). Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach. Retrovirology, 12(102).

Jenabian, M.-A., El-Far, M., Vyboh, K., et al. (2015). Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection. The Journal of Infectious Diseases, 212(3), 355–366.

DaFonseca, S., Niessl, J., Pouvreau, S., et al. (2015). Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology, 12(38).

Jenabian, M.-A., Talla, F., Talla, P., et al. (2015). Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays. Nigerian Medical Journal, 56(6), 420–424.

Trottier, B., Galanakis, C., Longpré, D., et al. (2015). Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054). HIV Clinical Trials, 16(3), 111–116.

Jenabian, M.-A., Costiniuk, C.T., Mboumba Bouassa, R.S., Chapdeleine Mekue Mouafo, L., Brogan, T.V. et Bélec, L. (2015). Tackling virological failure in HIV-infected children living in Africa. Expert Review of Anti-infective Therapy, 13(10), 1213–1223.

LeGoff, J., Roques, P., Jenabian, M.-A., et al. (2015). Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2. Clinical Microbiology and Infection, 21(9), 873.e1–873.e9.

Costiniuk, C.T. et Jenabian, M.-A. (2014). Cell-to-cell transfer of HIV infection: implications for HIV viral persistence. The Journal of General Virology, 95(Pt 11), 2346–2355.

Carriere, M., Lacabaratz, C., Kok, A., et al. (2014). HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response. The Journal of Infectious Diseases, 209(9), 1321–1330.

Mehraj, V., Jenabian, M.-A., Vyboh, K. et Routy, J.-P. (2014). Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy. Open AIDS Journal, 8, 66–78.

Costiniuk, C.T., Sigal, A., Jenabian, M.-A., Nijs, P. et Wilson, D. (2014). Short communication: Lower baseline CD4 count is associated with a greater propensity toward virological failure in a cohort of South African HIV patients. AIDS Research and Human Retroviruses, 30(6), 531–534.

Jenabian, M.-A., Patel, M., Kema, I., et al. (2014). Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection. Clinical and Experimental Immunology, 178(1), 102–111.

Costiniuk, C.T. et Jenabian, M.-A. (2014). The lungs as anatomical reservoirs of HIV infection. Reviews in Medical Virology, 24(1), 35–54.

Lebouché, B., Jenabian, M.-A., Singer, J., et al. (2014). The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy – CTN PT006: study protocol for a randomized controlled trial. Trials, 15(390).

Moussa, S., Jenabian, M.-A., Gody, J.C., et al. (2013). Adaptive HIV-specific B cell-derived humoral immune defenses of the intestinal mucosa in children exposed to HIV via breast-feeding. PLoS One, 8(5).

Jenabian, M.-A., Patel, M., Kema, I., et al. (2013). Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers. PLoS One, 8(10).

Koyalta, D., Jenabian, M.-A., Djouater, B., et al. (2013). Field evaluation in Chad of community usage of CD4 T lymphocyte counting by alternative single-platform flow cytometry. BMC Health Services Research, 13(373).

Jenabian, M.-A., Nicolette, C.A., Tcherepanova, I.Y., Debenedette, M.A., Gilmore, N. et Routy, J.-P. (2013). Impact of autologous dendritic cell-based immunotherapy (AGS-004) on B- and T-cell subset changes and immune activation in HIV-infected patients receiving antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 64(4), 345–350.

Jenabian, M.-A., Seddiki, N., Yatim, A., et al. (2013). Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection. PLoS Pathogens, 9(4).

Koyalta, D., Jenabian, M.-A., Nadjiouroum, N., et al. (2013). Single-platform, volumetric, CD45-assisted pan-leucogating flow cytometry for CD4 T lymphocytes monitoring of HIV infection according to the WHO recommendations for resource-constrained settings. BMC Research Notes, 6(169).

Bernier, A., Cleret-Buhot, A., Zhang, Y., et al. (2013). Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication. Retrovirology, 10(160).

Jenabian, M.-A., Ancuta, P., Gilmore, N. et Routy, J.-P. (2012). Regulatory T cells in HIV infection: can immunotherapy regulate the regulator? Clinical and Developmental Immunology, 2012, Article ID 908314.

Saidi, H., Jenabian, M.-A. et Belec, L. (2012). Understanding factors that modulate HIV infection at the female genital tract mucosae for the rationale design of microbicides. AIDS Research and Human Retroviruses, 28(11), 1485–1497.

Nikolova, M., Carriere, M., Jenabian, M.-A., et al. (2011). CD39/adenosine pathway is involved in AIDS progression. PLoS Pathogens, 7(7).

Belec, L., Jenabian, M.-A., Charpentier, C. et Saidi, H. (2011). Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicide. Future Microbiology, 6(7), 731–737.

Charpentier, C., Koyalta, D., Ndinaromtan, M., et al. (2011). Distribution of HIV-1 and HSV-2 epidemics in Chad revealing HSV-2 hot-spot in regions of high-risk HIV spread. Journal of Infection in Developing Countries, 5(1), 64–67.

Charpentier, C., Jenabian, M.-A., Piketty, C., et al. (2011). Dynamics of enfuvirtide resistance mutations in enfuvirtide-experienced patients remaining in virological failure under salvage therapy. Scandinavian Journal of Infectious Diseases, 43(5), 373–379.

Auvert, B., Jenabian, M.-A., Saidi, H., Lissouba, P. et Belec, L. (2011). Partial inactivation of CCR5- and CXCR4- tropic HIV-1 by human urine. Archives of Virology, 156(12), 2181–2186.

Jenabian, M.-A., Saidi, H., Charpentier, C., et al. (2010). Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization. AIDS Research and Therapy, 7(16).

Jenabian, M.-A., Auvert, B., Saidi, H., Lissouba, P., Matta, M. et Belec, L. (2010). Potent in vitro inactivation of both free and cell-associated CCR5- and CXCR4-tropic HIV-1 by common commercial soap bars from South Africa. Journal of Acquired Immune Deficiency Syndromes, 54(4), 340–342.

Metlas, R.M., Srdic, T.V., Jenabian, M.-A., et al. (2009). Immunoglobulin G-reactive antibodies from sera of healthy individuals enriched in IgG2--therapeutic potential in HIV-1 infection. Current HIV Research, 7(4), 378–383.

Jenabian, M.-A., Saidi, H., Charpentier, C., et al. (2009). In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20). The Journal of Antimicrobial Chemotherapy, 64(6), 1192–1195.

Eslahpazir, J., Jenabian, M.-A., Bouhlal, H., et al. (2008). Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions. Clinical and Vaccine Immunology (CVI), 15(5), 872–884.

Saidi, H., Jenabian, M.-A., Gombert, B., Charpentier, C., Mannarini, A. et Belec, L. (2008). Pre-clinical development as microbicide of zinc tetra-ascorbo-camphorate, a novel terpenoid derivative: potent in vitro inhibitory activity against both R5- and. AIDS Research and Therapy, 5(10).

Saidi, H., Nasreddine, N., Jenabian, M.-A., et al. (2007). Differential in vitro inhibitory activity against HIV-1 of alpha-(1-3)- and alpha-(1-6)-D-mannose specific plant lectins: implication for microbicide development. Journal of Translational Medicine, 5(28).


Direction (Depuis 1990) et d’essais doctoraux (depuis 2014)

  • Aucune donnée disponible pour cette section.

Autres directions et supervisions

Aucune donnée disponible pour cette section.


  • Aucune donnée disponible pour cette section.


  • Aucune donnée disponible pour cette section.

Participation à l'édition d'une revue

  • Medicine: Academic editor - Infectious Diseases

Services à la collectivité

Membre, Comité institutionnel de protection des animaux (CIPA)